Today, Dec. 18, 2025, a bullish analyst call spotlights Rivian’s R2 roadmap, autonomy push, and evolving EV strategy.

Jim Boyle, Medline CEO, celebrates with others as medical supplies giant Medline (MDLN) holds it's IPO at Nasdaq stock market ...

Shares are getting a boost from Baird’s upgrade as well as new features and updates for its R1 SUVs. The update to the ...

Rivian has just shared details of its latest over-the-air software update 2025.46, which includes some of the new features ...

For the nine months ended September 27, 2025, Medline generated $20.6 billion in net sales and $1 billion in net income, with an Adjusted EBITDA of $2.7 billion. For the full year 2024, the company ...

The shares are indicated at $33.50 each, versus the IPO price of $29. Medline, which counts Blackstone Inc., Carlyle Group ...

Rivian stock had been trending upward recently despite facing challenges. Here is a look at where the stock could be in a ...

At $6.26 billion, Medline is just the fifth US-listed firm to raise more than $5 billion in an IPO over the past decade, data ...

Medline, a medical-supplies manufacturer and distributor, raised $6.26 billion in its initial public offering, notching the largest IPO since 2021. The Blackstone- and Carlyle\-backed company sold 216 ...

Due to complications in its supply chain, it has consistently fallen short of its 200,000 annual vehicle production target. In 2024, Rivian produced 49,476 vehicles and suggested minimal growth -- if ...